Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
38,346,880
-
Total 13F shares
-
25,370,464
-
Share change
-
+24,706,770
-
Total reported value
-
$433,824,000
-
Price per share
-
$17.12
-
Number of holders
-
46
-
Value change
-
+$422,462,101
-
Number of buys
-
45
Institutional Holders of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) as of Q4 2021
As of 31 Dec 2021 Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) had 46 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 25,370,464 shares of stock of the company.
Largest 10 holders included BAKER BROS. ADVISORS LP, MPM ASSET MANAGEMENT LLC, 5AM Venture Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, StepStone Group LP, TCG Crossover Management, LLC, 72 Investment Holdings, LLC, and GOLDMAN SACHS GROUP INC.
This table shows 46 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.